{"id":784284,"date":"2023-09-15T08:26:47","date_gmt":"2023-09-15T12:26:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/"},"modified":"2023-09-15T08:26:47","modified_gmt":"2023-09-15T12:26:47","slug":"cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/","title":{"rendered":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWARK, Calif., Sept.  15, 2023  (GLOBE NEWSWIRE) &#8212; CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that members of its management team will participate in the Cantor Global Healthcare Conference, September 26-28<sup>th<\/sup> at the InterContinental Barclay Hotel in New York.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"max-width:38%;min-width:38%\">\n            <em><br \/>\n              <strong><br \/>\n                <u>Cantor Global Healthcare Conference<\/u><br \/>\n              <\/strong><br \/>\n            <\/em>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%\">Date:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">Wednesday, September 27<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>10:20am Eastern Time<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"http:\/\/ir.cymabay.com\/events\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.cymabay.com\/events<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<p align=\"left\">\n        <strong>About CymaBay<br \/><\/strong>CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. Our deep understanding of the underlying mechanisms of liver inflammation and fibrosis, and the unique targets that play a role in their progression, have helped us receive breakthrough therapy designation (U.S. Food and Drug Administration), Priority Medicines status (European Medicines Agency) and orphan drug status (U.S. and Europe) for seladelpar, a first-in-class investigational treatment for people with PBC. Our evidence-based decision-making and commitment to the highest quality standards reflect our relentless dedication to the people, families, and communities we serve. To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3wLxrE0UzXSmjMC4JovxuCg5zdh47fIg0oNSfqhBu54Y6VS-qq5WWrVUhLmPTVXjn0Jkxgvy7X8FKHiQH4p9Q9PxFTZ1Bnd2UkHAivaqcsoa9DZB_mTq8y0DJPPmG2EHAv73EjazZOKRGEHM2fkKyuP5yucD-Bh7vE7cCip8iUwKM4sJnFGrlxomH4naMBGgkxr1_a-Tq63D4cZjPLvMf65_NJtrdhMgMnnbZVAbhHo=\" rel=\"nofollow noopener\" target=\"_blank\">www.cymabay.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZHJFG8BzDfFWLYNAMGMeMCiNxHKKDgqXwcm9Yt1DpRoeYGgfWTiwYpBaAflLL65cRLjjXe3pCVHpqbMC8ZojRKoRIJgdSifZpz86_MN5J30=\" rel=\"nofollow noopener\" target=\"_blank\">X (formerly Twitter)<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uSgZotOQDFEmOoLlbwXWckQMIbLS8n7OtuJ82JRHRZnI5ZZKVlgBWwfW04Zlqs_066Wb7h2TQ1hExIzc2SIMDe0IAUGI2PhU_0hsdA9vUBxjMYnulysnvQmXNZM43-AH\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">For additional information about CymaBay visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3wLxrE0UzXSmjMC4JovxuNevgE0mMafYkDtVXbwMJGmCN6FEYE03az3A8V1rdiVZYE39RUz_ZvipfNMplftjH0AqtA460CqQ_6m2LKRxUKgp3C2p01Vtyf-P2P37pdreNucM5COIN5EuVBxNeN6Tph5YHcHxK3SHa2hJKLNCx4_8PvcAlqxa7uXS6H8svTawj_p_iyO_BEram8iQnY-nFo4zLn4VrJOLH_A4AD0JdgU=\" rel=\"nofollow noopener\" target=\"_blank\">www.cymabay.com<\/a>.<\/p>\n<p>\n        <strong>Public Relations Contact<\/strong><br \/>\n        <strong>:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>\u00a0<\/strong><\/p>\n<p>Theresa Dolge<br \/>Evoke Kyne<br \/>(609) 915-2156 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iKm_EzbwRV2kDvJ8OGf87zhtkDmKS3d89NuGn35wb_kV3r3Gqa3QXUx7_RuscP3Xc5sppdI8ktXWmosWP3JUAFPnyrORbaOuB1PirPtjyj1YKzoFSbCwxD_-EKIMHlI2\" rel=\"nofollow noopener\" target=\"_blank\">Theresa.Dolge@evokegroup.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong>\n      <\/p>\n<p>Hans Vitzthum<br \/>LifeSci Advisors, LLC<br \/>(617) 430-7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jn_hJH5f-M8OhzIng3FEWMagw_CmfXYsK0BPh2dq1XqIkHWkv5zcao21bkmBfzYyKJeNDP739Q7pM3u0MQzPUQdQPfTALlH3OdzUjR9ka7A=\" rel=\"nofollow noopener\" target=\"_blank\">Hans@LifeSciAdvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjViNTc4NDQtNzFhMy00ZDgyLThhYTYtZTdhNjI1NDJjNjY4LTEwMzkzODk=\/tiny\/CymaBay-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) &#8212; CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that members of its management team will participate in the Cantor Global Healthcare Conference, September 26-28th at the InterContinental Barclay Hotel in New York. Cantor Global Healthcare Conference \u00a0 Date: Wednesday, September 27 Time: 10:20am Eastern Time Format: Fireside Chat Webcast: http:\/\/ir.cymabay.com\/events About CymaBayCymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. Our deep understanding of the underlying mechanisms of liver inflammation and fibrosis, and the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784284","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) &#8212; CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that members of its management team will participate in the Cantor Global Healthcare Conference, September 26-28th at the InterContinental Barclay Hotel in New York. Cantor Global Healthcare Conference \u00a0 Date: Wednesday, September 27 Time: 10:20am Eastern Time Format: Fireside Chat Webcast: http:\/\/ir.cymabay.com\/events About CymaBayCymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. Our deep understanding of the underlying mechanisms of liver inflammation and fibrosis, and the &hellip; Continue reading &quot;CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-15T12:26:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference\",\"datePublished\":\"2023-09-15T12:26:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/\"},\"wordCount\":247,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/\",\"name\":\"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\",\"datePublished\":\"2023-09-15T12:26:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk","og_description":"NEWARK, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) &#8212; CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that members of its management team will participate in the Cantor Global Healthcare Conference, September 26-28th at the InterContinental Barclay Hotel in New York. Cantor Global Healthcare Conference \u00a0 Date: Wednesday, September 27 Time: 10:20am Eastern Time Format: Fireside Chat Webcast: http:\/\/ir.cymabay.com\/events About CymaBayCymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies. Our deep understanding of the underlying mechanisms of liver inflammation and fibrosis, and the &hellip; Continue reading \"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-15T12:26:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference","datePublished":"2023-09-15T12:26:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/"},"wordCount":247,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/","name":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=","datePublished":"2023-09-15T12:26:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjc4OCM1ODE2MTY2IzIwMjgzMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cymabay-therapeutics-to-present-at-the-cantor-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CymaBay Therapeutics to Present at the Cantor Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784284"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784284\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}